Kcne2 -/mice from Kcne2 +/-× Kcne2 +/crosses have normal echocardiographic parameters and ventricular myocyte size 19 . In contrast, when we bred Kcne2 -/pups from Kcne2 -/-× Kcne2 -/crosses, we found that they showed striking cardiomegaly: more than twofold increased heart mass and more than threefold increased heart weight to body weight ratio, at 3 weeks ( Fig. 1a) . Three-week-old Kcne2 -/pups derived from Kcne2 -/dams also showed >50% increases in end-diastolic left ventricular internal diameter, left ventricular anterior and posterior wall thickness and a 45% decrease in fractional shortening (Fig. 1b,c) . The anterior and posterior wall thickening are indicators of cardiac hypertrophy, which was probably the primary effect of Kcne2 deficiency; the left ventricular dilation and reduced fractional shortening probably arose from a compensatory response (that is, the Frank-Starling mechanism 20 ) to the impaired contractility resulting from sustained hypertrophy.
Ventricular myocytes of 3-week-old Kcne2 -/pups from homozygous crosses had a twofold larger membrane capacitance than those from age-matched Kcne2 +/+ pups, also indicative of hypertrophy (defined as increased organ or tissue size due to an increase in the size of the constituent cells) (Fig. 1d) . The raw amplitudes of two of the predominant mouse ventricular repolarization K + currents, the slow-activating delayed rectifier K + current termed I K,slow and the fast component of the transient outward K + current (I to,f ), were unaltered by Kcne2 disruption, but, because of the doubling in capacitance, there was a halving in density for each of these currents ( Fig. 1d-f) . In contrast, the raw amplitude of the steady-state K + current (I ss ) doubled, such that its density did not change with Kcne2 disruption (Fig. 1d,f) .
Hearts from 3-week-old Kcne2 -/mice from Kcne2 -/dams ( Fig. 1g ) also showed marked left ventricular fibrosis and papillary muscle degeneration, necrosis and mineralization-features of sustained hypertrophy (Fig. 1h) . We also observed hepatic fibrosis, suggesting right heart failure (Fig. 1i) , and an unusually pale appearance of the liver (Fig. 1g) , possibly indicative of hepatic steatosis. Furthermore, although the hearts of 3-month-old Kcne2 -/mice bred from Kcne2 +/dams appeared to be structurally normal 19 , hearts of 1-year-old Kcne2 -/mice bred from Kcne2 +/dams showed cardiomegaly with left ventricular fibrosis (Fig. 1j) . In sum, it is apparent that parental genotype strongly influences the cardiac phenotype of Kcne2 -/offspring. 
Kcne2 -/mice show dwarfism and alopecia Aside from their cardiac pathology, Kcne2 -/mice showed other gross abnormalities that were influenced by the maternal Kcne2 -/genotype. Pups from Kcne2 -/dams showed 50% embryonic lethality, whether the sire was Kcne2 -/or Kcne2 +/-( Fig. 2a) . Maternal genotype was the determining factor in litter size: litters from Kcne2 +/dams with Kcne2 -/sires were of normal size, and surviving pups in litters from both types of Kcne2 -/-× Kcne2 +/crosses showed an approximately mendelian distribution ( Fig. 2a) . Kcne2 -/pups from Kcne2 -/dams also showed severe dwarfism ( Fig. 2b,c) . Although birth weights were similar in all cases, the mean body weight of pups from Kcne2 -/-× Kcne2 -/crosses was 40% lower than that of pups from Kcne2 +/+ × Kcne2 +/+ crosses at 5 weeks of age ( Fig. 2d) . Reduced body mass correlated with the maternal Kcne2 -/genotype, but also to pup genotype, as pups from Kcne2 +/− sires were significantly larger than those from Kcne2 -/sires (both with Kcne2 -/dams) ( Fig. 2d) . By 15 weeks of age, mean body weights were similar regardless of pup genotype ( Supplementary Fig. 1a ).
Radiological examination revealed retarded skeletal development in the Kcne2 -/pups, producing dwarfism due to slow growth of both long bones and vertebrae ( Fig. 2c) . This effect was also apparent from the presence of larger epiphyseal gaps and less ossification of the epiphyses in the large joints compared to those of Kcne2 +/+ pups. The large joints of Kcne2 -/pups were irregularly shaped, fragmented and heterogeneously sclerotic, defects characteristic of slow multifocal ossification ( Fig. 2c) .
Unexpectedly, Kcne2 -/pups from homozygous crosses also showed marked alopecia of the trunk, which began at 1-2 weeks of age and peaked at 4-5 weeks ( Fig. 2b,e-g) . We also observed alopecia in aging Kcne2 -/mice from Kcne2 +/-× Kcne2 +/crosses, initiating between the ears and then spreading posterodorsally, with an abrupt loss of mature hair follicles at the transition zones ( Fig. 2h-j) .
Kcne2 -/phenotype is attenuated by T 3 and T 4 or surrogacy
Considering the combination of cardiac hypertrophy, cardiac and hepatic fibrosis, dwarfism, alopecia and skeletal abnormalities indicative of retarded development in Kcne2 -/pups, we investigated whether hypothyroidism might be the underlying cause. We first determined serum thyroid hormone concentrations. Indeed, the mean serum T 4 concentration in 3-week-old Kcne2 -/pups from Kcne2 -/-× Kcne2 -/crosses was 40% lower, and the mean serum thyroid-stimulating hormone (TSH) concentration twofold greater, than in age-matched Kcne2 +/+ pups from Kcne2 +/+ × Kcne2 +/+ crosses ( Fig. 3a) , confirming hypothyroidism in the Kcne2 -/pups. Serum T 4 and TSH concentrations were, however, normal in virgin 3-to 6-month-old Kcne2 -/mice from Kcne2 +/-× Kcne2 +/crosses ( Supplementary Fig. 2) , consistent with growth, litter size, and cardiac morphology trends (see Fig. 2 and ref. 19 ). By 12-15 months of age, T 4 and TSH concentrations were trending down and up, respectively, in Kcne2 -/mice bred from Kcne2 +/-× Kcne2 +/crosses ( Supplementary  Fig. 2) , consistent with a latent hypothyroidism and the late onset of alopecia ( Fig. 2h) , cardiac hypertrophy and fibrosis ( Fig. 1j) . Thyroid glands from aged Kcne2 -/mice bred from Kcne2 +/-× Kcne2 +/crosses had a 40% greater mean mass post-mortem than thyroid glands from age-matched Kcne2 +/+ mice bred from Kcne2 +/-× Kcne2 +/crosses, whereas thyroid glands from age-matched Kcne2 +/mice bred from Kcne2 +/-× Kcne2 +/crosses had intermediate mean mass, indicative of goiter formation due to Kcne2 disruption (Fig. 3b) . In contrast to virgin adult mice, pregnant Kcne2 -/dams showed a 62% lower mean serum T 4 concentration than pregnant Kcne2 +/+ dams ( Fig. 3c ), suggesting an explanation for the exaggerated phenotype and small litter size of Kcne2 -/pups bred from Kcne2 -/dams ( Fig. 2) . Consistent with previous reports for mice and rats (but in contrast to humans) 21, 22 , pregnant mice in our study showed lower serum T 4 concentrations than did age-and genotyped-matched virgin adults ( Fig. 3c and Supplementary Fig. 2 ). 
We next tested whether or not switching Kcne2 -/litters with the litters of Kcne2 +/+ dams (surrogacy) as soon as possible after birth and through to weaning, such that Kcne2 -/pups were fed exclusively by Kcne2 +/+ dams, would alleviate any of the observed abnormalities. Notably, normal body weight was fully restored in Kcne2 -/pups from Kcne2 -/-× Kcne2 -/crosses by surrogacy with Kcne2 +/+ dams ( Fig. 3d,e ). Conversely, surrogacy of Kcne2 +/+ pups with Kcne2 -/dams from birth through to weaning resulted in a mean preweaning body weight similar to that of Kcne2 -/pups and an intermediate body weight in pups after weaning ( Fig. 3d,e ). These data suggested the possibility that maternal thyroid hormones passed through milk, perhaps at higher concentrations, or in higher volumes of milk, from wild-type dams, were compensating for the defect in Kcne2 -/pups. Confirming the role of thyroid hormone in body weight differences, Kcne2 -/pups born from Kcne2 -/dams and Kcne2 -/sires and raised by Kcne2 -/dams showed markedly improved body weight by 3 weeks of age after T 3 and T 4 administration every 48 h from birth ( Fig. 3e and Supplementary Fig. 1b ). Furthermore, T 4 supplementation of Kcne2 -/dams from 2 weeks before birth to weaning resulted in normal pup body weight ( Fig. 3e) .
Dermatological disorders occur frequently in hypothyroidism 23 . Notably, we found that alopecia was completely reversed in five of five adult Kcne2 -/mice evaluated, with 2 weeks administration of T 3 and T 4 every other day (examples are shown in Fig. 3f,g) . Alopecia was also completely reversed in 19 of 21 Kcne2 -/pups after 10 d of T 3 and T 4 administration every other day, in 19 of 20 Kcne2 -/pups by surrogacy with Kcne2 +/+ dams and in 16 of 16 Kcne2 -/pups by T 4 supplementation of their mothers from 2 weeks before birth to weaning. Conversely, we observed alopecia in 13 of 23 Kcne2 +/+ pups surrogated with Kcne2 -/dams ( Fig. 3g) .
Hypothyroidism is associated with dilated and hypertrophic cardiomyopathies, reduced fractional shortening and heart failure 24 . Supporting a link between these cardiac defects and the hypothyroidism that we observed in Kcne2 -/mice, surrogacy of Kcne2 -/pups with Kcne2 +/+ dams resulted in a marked reduction in the relative mass of the heart compared to body mass; conversely, surrogacy of Kcne2 +/+ pups with Kcne2 -/dams had the opposite effect ( Fig. 3h,i) . As observed with nonsurrogated Kcne2 -/pups ( Fig. 1g) , the liver of Kcne2 +/+ pups surrogated with Kcne2 -/dams had an unusually pale appearance, possibly indicative of hepatic steatosis (Fig. 3h) . Furthermore, echocardiography revealed beneficial effects of surrogacy of Kcne2 -/pups with Kcne2 +/+ dams: in these pups, there was a significant reduction in ventricular wall thickness and chamber diameter and increased fractional shortening compared to nonsurrogated Kcne2 -/pups (Fig. 3j ).
KCNE2 and KCNQ1 form a TSH-stimulated thyrocyte K + channel
Previous studies have indicated that KCNE2 forms heteromeric channels with the KCNQ1 K + channel α subunit in gastric epithelium 14, 15, 25, 26 .
Here we found that both KCNE2 and KCNQ1 are expressed in human ( Fig. 4a) and mouse ( Fig. 4b-d ) thyroid glands (we used hyperplastic human thyroid tissue to permit better distinction between the apical and basolateral membranes). In both human and mouse thyroid, KCNE2 and KCNQ1 partially co-localized with NIS, the basolateral membrane glycoprotein that mediates active Itransport, the first step in thyroid hormone biosynthesis. Furthermore, thyroid follicular epithelia in Kcne2 -/mice showed abnormal architecture; compared to thyrocytes in Kcne2 +/+ mice, Kcne2 -/thyrocytes were often flattened and were less abundant (Fig. 4e,f) . We next sought to determine whether KCNQ1-KCNE2 K + currents were expressed in thyrocytes by using the rat thyroid-derived FRTL5 cell line. We detected endogenously expressed KCNQ1 and KCNE2 proteins, whose expression was upregulated by TSH or its major downstream effector, cyclic AMP, in FRTL5 cell membrane fractions ( Fig. 4g) . We next measured endogenous currents from FRTL5 cells using patch-clamp recording in the whole-cell configuration. A TSH-stimulated K + current in FRTL5 cells bore the signature linear current-voltage relationship of KCNQ1-KCNE2 channels and was inhibited by the KCNQ-specific antagonist XE991 (Fig. 4h,i) . In sum, KCNQ1-KCNE2 channels are expressed in human and rodent thyrocytes, where they generate a TSH-stimulated, constitutivelyactive K + current.
KCNE2 is required for normal thyroid Iaccumulation
Thyroid hormone requirements are especially high in early development. Developing fetuses and neonates rely not only on their own thyroid hormone biosynthesis but also on maternal T 4 in utero and perhaps maternal T 4 present in milk. We therefore examined thyroid Iaccumulation, a key step in thyroid hormone biosynthesis, in lactating dams and their pups. We injected 124 I into the tail vein of lactating dams; the dams were then placed together again with their pups to Kcne2 -/dams showed a striking defect in 124 I accumulation in the thyroid, with 65% less accumulation over the first hour after injection and continuing deficiency in the following 3 d, compared to Kcne2 +/+ dams (Fig. 5a-c) . In pups whose sole source of 124 I was dams' milk, Kcne2 deletion caused an 80% reduction in pup thyroid 124 I accumulation 24 h after injection of dams, and continuing deficiency for the following 2 d (Fig. 5d,e) . When normalized to stomach 124 I count, the thyroid 124 I count was reduced 87% in Kcne2 -/pups compared to Kcne2 +/+ pups at 72 h after injection of the dam (Fig. 5f) .
Thus, Kcne2 deletion causes a thyroid Iaccumulation defect, which, in turn, causes a thyroid hormone biosynthesis defect, the gross phenotypic effects of which are particularly striking in pups feeding from Kcne2 -/dams. To examine the mechanistic basis for this phenotype, and for the beneficial effects of surrogacy by Kcne2 +/+ dams, we first performed PET on pups surrogated with dams of opposite genotype. We performed tail vein injections of lactating dams with 124 I followed by imaging of the pups feeding from them. Of note, we found that Kcne2 -/pups feeding from Kcne2 +/+ dams had higher stomach and thyroid 124 I counts (measured as peak counts per ml), and higher thyroid to stomach count ratios, than did Kcne2 +/+ pups feeding from Kcne2 -/dams (Fig. 6a-c) . This suggested that the surrogating dams' genotype was crucial in determining thyroid 124 I uptake of pups. However, pup genotype also had a notable effect, because when pups of either genotype were fed from Kcne2 +/+ dams, Kcne2 +/+ pups still had an almost twofold higher thyroid to stomach count ratio at 48-72 h compared to Kcne2 -/pups ( Figs. 5f and Fig. 6c ).
We also quantified thyroid radioactive iodide uptake (RAIU), a measure of the efficiency of the thyroid at accumulating 124 I from the available total body 124 I, for all surrogated and nonsurrogated pups (Fig. 6d) . Total thyroid 124 I counts were higher in both Kcne2 +/+ and Kcne2 -/pups when feeding from Kcne2 +/+ dams than when feeding from Kcne2 -/dams, whereas total body 124 I counts were significantly higher only for Kcne2 -/pups feeding from Kcne2 +/+ dams compared to other groups (Fig. 6d) . In contrast, thyroid RAIU was significantly higher only in Kcne2 +/+ pups feeding from Kcne2 +/+ dams compared to other groups (Fig. 6d) . These data demonstrate again that Kcne2 -/pups' thyroids are less efficient than those of Kcne2 +/+ pups at accumulating I -, but also indicate that Kcne2 -/dams supply less Ito their pups than do Kcne2 +/+ dams. These results also indicate that Kcne2 -/pups are better at accumulating total body Ithan are Kcne2 +/+ pups.
To examine the poor delivery of Ifrom Kcne2 -/dams, we compared milk ejection from Kcne2 +/+ and Kcne2 -/dams by weighing pups before and after feeding, as previously described 27 . Kcne2 -/dams had a highly significant milk ejection defect, manifested as pups (of either genotype) failing to gain weight (from milk ingestion) during the first 30 min of feeding from Kcne2 -/dams, in sharp contrast to pups feeding from Kcne2 +/+ dams (Fig. 6e) . We observed similar results over the first 60 min of feeding ( Supplementary  Fig. 3) . Notably, Kcne2 +/+ and Kcne2 -/pups showed no significant dam genotype-independent differences in their feeding rates, as measured by weight gain (Fig. 6e and Supplementary Fig. 3) . Furthermore, pups were latched on to dams of either genotype for the entire period under study (30 or 60 min). Thus, the milk ejection defects of Kcne2 -/dams were not related to behavioral differences in either pups or dams. Hypothyroid rats have previously been shown to have impaired milk ejection owing to reduced serum oxytocin compared to euthyroid rats 27 . Accordingly, we found that injection of Kcne2 -/dams with oxytocin returned their milk ejection to the same level as that of Kcne2 +/+ dams (Fig. 6e) . The milk ejection defect was probably a dominant factor in the beneficial effects of Kcne2 +/+ surrogacy and the negative effects of Kcne2 -/surrogacy. Additionally, however, milk from Kcne2 -/dams contained only half as much T 4 as that from Kcne2 +/+ dams (Fig. 6f) , potentially also contributing to the observed effects of surrogacy. Finally, to address the superior total body accumulation of Iby Kcne2 -/pups, we found equal serum Iconcentrations in nonsurrogated 3-week-old Kcne2 +/+ and Kcne2 -/pups ( Fig. 6g) , suggesting that, despite inferior milk ejection by Kcne2 -/dams, Kcne2 -/pups were able to maintain normal plasma Iconcentrations. This was not unexpected, given that hypothyroidism is known to result in decreased Iexcretion 28 .
DISCUSSION
More than a decade ago, KCNQ1 messenger RNA was found to be expressed at a higher level in human thyroid than in the heart or stomach 29 , but its role in the thyroid has not previously been reported. Furthermore, Kcnq1 gene-disrupted mice, like the Kcne2 -/mice described here, were previously found to have enlarged hearts and thickened ventricular walls, but the mechanistic basis for this was not described 30, 31 .
T 3 and T 4 biosynthesis requires active Itransport in the thyroid, where Iconcentrations reach 20-40 times that of the plasma. NIS, located on the basolateral side of thyrocytes, which are thyroid epithelial cells that encircle the colloid, transports Iinto the thyrocyte; at the cell-colloid interface, Iion is oxidized and covalently incorporated into thyroglobulin for thyroid hormone production 17 . NIS function requires a basolateral Na + /K + ATPase for Na + efflux, but the necessity for other channels or transporters in this process is not known. Here we identify KCNQ1-KCNE2 as a TSH-stimulated thyrocyte K + channel crucial for normal thyroid Iaccumulation and probably expressed predominantly at the basolateral membrane.
The marked effects of surrogacy in the current study add to the debate over whether maternal T 4 is at high enough concentrations in milk to deliver therapeutic effects in hypothyroxinemic newborns 32 . Our findings suggest that, at least in mice, T 4 is at a high enough concentration in milk to be potentially therapeutic for hypothyroxinemic pups. Maternal Kcne2 deficiency reduced the amount of T 4 in milk and impaired milk ejection, with both defects likely contributing to the poor development of pups feeding from Kcne2 -/dams. The mechanisms underlying the whole-animal and molecular effects of surrogacy seem to be complex, as one would expect. Kcne2 -/pups are less efficient at accumulating thyroid Icompared to Kcne2 +/+ pups when both are fed by Kcne2 +/+ dams, but have similar ability to accumulate thyroid Iwhen fed by Kcne2 -/dams. We speculate that a defect in thyroid Iaccumulation in Kcne2 -/pups is partially balanced by other factors, including adaptation to their development in a low maternal T 4 environment in the womb and their being initially fed with poorly ejected, low-T 4 milk. Part of this adaptation might involve reduced Iexcretion by Kcne2 -/pups, consistent with previous reports showing reduced Iexcretion in hypothyroidism 28 . The phenotypes described here for Kcne2 -/pups bred from homozygous Kcne2 -/crosses include features, such as alopecia and cardiac hypertrophy, not always observed in hypothyroid mouse models 33 . This apparent discrepancy may at least partly be explained by the fact that we studied Kcne2 -/pups derived from Kcne2 -/dams, whereas heterozygous crosses are typically used. It may also point to additional pathogenesis caused by Kcne2 deficiency beyond thyroid impairment that is treatable by thyroid hormone supplementation.
As is also the case for NIS 16, 34 , KCNQ1 is expressed in both thyroid and mammary gland epithelium; in the mammary gland, KCNQ1 may assemble with KCNE3 to contribute to K + homeostasis 35 . Although a role for KCNE2 in mammary epithelial function should not be ruled out, our PET data indicate that mammary gland Iuptake is not impaired in Kcne2 -/dams.
Human thyroid dysfunction negatively affects the brain, heart and gastrointestinal tract; fatalities may occur from thyroid storm in hyperthyroidism and myxedema coma in hypothyroidism 36 . In addition, thyroid dysfunction during pregnancy increases the risk of adverse maternal and fetal outcomes [37] [38] [39] . Subclinical human maternal hypothyroxinemia causes severe neurodevelopmental disorders 40 , may cause changes in blood lipid profile, myocardial function and neuropsychiatric function [41] [42] [43] , and is an independent risk factor in heart failure due to structural and electrical remodeling in the heart 24 . Notably, a single nucleotide polymorphism near KCNE2 was recently shown to associate with early-onset myocardial infarction 44 , suggesting the possibility of a genetic link to previously reported subclinical hypothyroidism-associated accelerated coronary artery disease and myocardial infarction 45 .
Subclinical hypothyroidism is also associated with a prolonged corrected QT interval on the electrocardiogram 46 , a hallmark of loss-of-function mutations in KCNE2 and KCNQ1 3, 6 , and with atrial fibrillation, an increasingly prevalent disease in the aging population 47, 48 that is also associated with some KCNQ1 and KCNE2 gene variants 9, 12 . As many as 13% of individuals with idiopathic atrial fibrillation show biochemical evidence of hyperthyroidism 49 , and, in one study, 62% of 163 subjects reverted to sinus rhythm within 8-10 weeks after treatment for hyperthyroidism returned them to a euthyroid state 50 . The finding that KCNE2-KCNQ1 channels contribute to thyroid function raises the hypothesis that there is a thyroid component to some KCNE2-or KCNQ1-associated cardiac arrhythmias. In previous studies of sudden cardiac or unexplained death, it was often assumed that ion channel gene mutations were not causative in those cases showing overt structural heart disease upon autopsy 51 . Historically, 'electrical' heart diseases arising from ion channel defects have mostly been considered genetically distinct from 'structural' heart disease, although variants in the gene encoding the human SCN5A Na + channel have been associated with dilated cardiomyopathy 52 . Our findings suggest consideration of the possibility of a shared genetic basis for structural heart disease and cardiac arrhythmias in individuals showing both, given the possibility that mutations in KCNQ1 and KCNE2 could be arrhythmogenic-owing to primary electrical defects in myocyte K + channels containing these subunits-and also contribute to cardiac structural abnormalities, as a secondary effect of thyroid dysfunction due to defective thyroid KCNQ1-KCNE2 channels.
Identification of KCNE1-KCNQ2 as a thyrocyte channel important for Iaccumulation may also have therapeutic implications. Agonists and antagonists of KCNQ1-KCNE2 channels have already been developed. Because the pharmacology of KCNQ1-KCNE2 complexes is markedly different from that of homomeric KCNQ1, KCNQ1-KCNE1 or KCNQ1-KCNE3 channels 53 , identification of the requirement for KCNQ1-KCNE2 complexes for normal thyroid function may permit semispecific, reversible pharmacological targeting of the KCNQ1-KCNE2 complex to treat thyroid disease.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
Note: Supplementary information is available on the Nature Medicine website.
